Skip to main content
All lobbying filings

ARNOLD & PORTER KAYE SCHOLER LLP

Lobbying for SPYRE THERAPEUTICS, INC. · Biotechnology company focused on treatments for gastrointestinal and rheumatic diseases.

 Filing 2nd Quarter - Report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 17, 2026
Income
$10,000.00
What the client paid this registrant for the period.
Client based in
Massachusetts

Official filing document

 Government bodies contacted 5
  • Executive Office of the President (EOP)
  • Food & Drug Administration (FDA)
  • HOUSE OF REPRESENTATIVES
  • Office of Management & Budget (OMB)
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Lobbying activity 1
Health Issues

Issues related to monoclonal antibody products.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem